Nadolol 46708-0403-31
- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 8, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA211763
Need to source Nadolol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nadolol | 40 mg/1 |
Drug Class
beta-Adrenergic Blocker [EPC]Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]
Selected Package
46708-0403-31Selected100 TABLET in 1 BOTTLE (46708-403-31)
Other packages for this product(2)
30 TABLET in 1 BOTTLE (46708-403-30)
1000 TABLET in 1 BOTTLE (46708-403-91)